Liquid biopsies: the future of cancer early detection

Siobhan Connal, James M. Cameron, Alexandra Sala, Paul M. Brennan, David S. Palmer, Joshua D. Palmer, Haley Perlow, Matthew J. Baker

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)
8 Downloads (Pure)


Cancer is a worldwide pandemic. The burden it imposes grows steadily on a global scale causing emotional, physical, and financial strains on individuals, families, and health care systems. Despite being the second leading cause of death worldwide, many cancers do not have screening programs and many people with a high risk of developing cancer fail to follow the advised medical screening regime due to the nature of the available screening tests and other challenges with compliance. Moreover, many liquid biopsy strategies being developed for early detection of cancer lack the sensitivity required to detect early-stage cancers. Early detection is key for improved quality of life, survival, and to reduce the financial burden of cancer treatments which are greater at later stage detection. This review examines the current liquid biopsy market, focusing in particular on the strengths and drawbacks of techniques in achieving early cancer detection. We explore the clinical utility of liquid biopsy technologies for the earlier detection of solid cancers, with a focus on how a combination of various spectroscopic and -omic methodologies may pave the way for more efficient cancer diagnostics.
Original languageEnglish
Article number118
Number of pages18
JournalJournal of Translational Medicine
Issue number1
Publication statusPublished - 11 Feb 2023


  • liquid biopsy
  • multi-cancer
  • early detection
  • cancer
  • diagnostics


Dive into the research topics of 'Liquid biopsies: the future of cancer early detection'. Together they form a unique fingerprint.

Cite this